1 / 22

Physical and Mental Health Effects of Intimate Partner Violence

Physical and Mental Health Effects of Intimate Partner Violence. Jacquelyn C. Campbell, PhD, RN, FAAN Anna D. Wolf Chair & Professor Program Director, RWJF Nurse Faculty Scholars Johns Hopkins University School of Nursing. Definitional Issues.

genna
Télécharger la présentation

Physical and Mental Health Effects of Intimate Partner Violence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Physical and Mental Health Effects of Intimate Partner Violence Jacquelyn C. Campbell, PhD, RN, FAAN Anna D. Wolf Chair & Professor Program Director, RWJF Nurse Faculty Scholars Johns Hopkins University School of Nursing

  2. Definitional Issues • CDC: Physical and/or sexual violence (use of physical force) or threat of such violence; or psychological/ emotional abuse and/or coercive tactics when there has been prior physical and/or sexual violence; between persons who are spouses or non marital partners (dating, boyfriend-girfriend) or former spouses or non marital partners (Saltzman et.al. ‘99) • Versus emotional abuse/controlling behavior a form of violence • Gender Symmetry – Archer ‘00; Straus; Dutton • Risk factor for health problems versus diagnosis

  3. MMRW ‘08 – BRFSS ‘05 – 4 questions – physical &/or sexual or threats; weighted; 16 states • 600,000 injuries to men: 1.2 ml injuries to women • Lifetime IPV – 11.5% for men; 23.6% for women • Significantly higher (p<0.05) among multiracial, non-Hispanic & American Indian/ Alaska Native women; & lower-income respondents. • Average of 1200 IP homicides per year of women – 400 for men (BJS ‘06)

  4. U.S. PREVALENCE • 35% lifetime IPV (4.4 Million) (Commonwealth Fund - Plichta, ‘02) • 10.8% physical &/or sexual assault - past 2 years (Walton-Moss et al ’04)– approx same prevalence in MSM (Greenwood, Relf et. al. ’03) – significantly less - female same sex partners (T&T ’01) • 3.2% severely abused past year • 52% injured (NCVS – ‘06) • 20 - 35% seek medical care or hospitalized • 85% in the health care system for something (42% of femicide victims - Campbell et. al. ‘00)

  5. Intimate partner sexual violence May include… • Forced sex - by force or threat of force • Including forced sexual initiation – • 12.5% of women in US – 15-44 - report first sexual experience is forced (Stockman ’09) • For those whose first sex <15 – 21.5% • Painful sex - clearly indicated as unwanted • Sex without protection

  6. Overlap between physical, sexual and emotional abuse (N = 889) (Campbell et. al. ’02 from Ellsberg ’00) Sexual (N = 243) 32 (3.6) 31 (3.5) 14 (1.6) 166 (18.7) 177 (19.9) 166 (18.7) Emotional (N = 677) 303 (34.0) Physical (N = 649)

  7. PHYSICAL HEALTH EFFECTS • Physical Injury (Facial, fractures, dental, neurological - soft tissue, internal, “falls”- Grisso ‘91) • (TBI & Strangulation – McClane ‘05) • Neurological Sx - Coker ’00 • Stroke or Sx consistent w/stroke (Black ‘08; Loxton ‘06) • Chronic Pain (Back, abdominal, chest, head) (Campbell ‘00; Coker ‘02) • Fibromyalgia (Alexander ‘99; Walker ‘00) • Chronic Irritable Bowel Syndrome (Drossman ‘98) • Hypertension (Schollenberger et al ’02; Coker ’00) • Smoking (30-34% victims; 13-15% controls) (Letourneau ’99; MMWR ’08)

  8. New Data from BRFSS (MMWR ‘08) • Women -lifetime IPV • High Cholesterol: AOR 1.3 ([CI] = 1.1--1.4) • Disability AOR = 1.7; activity limitations 2.1 • Arthritis AOR = 1.6 • Heart Attack; Heart Disease;Stroke :1.4; 1.7; 1.8 • Smoking AOR = 2.3 • Risk factors for HIV/STD’s 3.1 (CI = 2.4--4.0). • Men: disability equipment, arthritis, asthma, activity limitations, stroke, risk factors for HIV infection or STDs, smoking, and heavy or binge drinking. (AOR’s 1.4 (CI = 1.0--2.0) - stroke to 2.6 (CI = 2.0--3.6) – HIV/STD risk

  9. HEALTH EFFECTS OF FORCED RELATIONSHIP SEX 40-45% of physically abused women INCREASED RISK OF: • Unintended pregnancy (Pallito et al ‘04) • Adolescent Pregnancy (Renker ‘02) • Abortion (Evins & Chescheir ‘96) • Vaginal bleeding (Campbell et. al. ‘01) • Anal & vaginal tearing (Campbell & Alford) • Painful intercourse (Eby et. al., ‘95; Coker ‘00; Leserman ‘98)

  10. HEALTH EFFECTS OF FORCED RELATIONSHIP SEX Increased Risk of: • STD’s (Eby et. al. ‘95; Coker ’99; BRFSS ‘08) • HIV/AIDS (Gielen ‘94,‘00; Maman ’00, ‘02; Dunkle ‘04) • Pelvic pain, Pelvic Inflammatory Disease, Infertility (Eby et.al. ‘95; Leserman ‘98; Schei ‘90) • Urinary Tract Infections (Campbell &Alford ‘89; Coker ‘99; Campbell et. al. ‘00) • Risk of homicide, low self esteem (Campbell ‘89;’99; ‘03) • Cervical Cancer (Coker et. al. ‘00)

  11. New Face of HIV/AIDS – HIV/VAW interface official recognition by UN ‘04 • Around globe women are the fastest group contracting HIV & fastest group converting to AIDS • In US – poor African American women most affected (Levenson – The Secret Epidemic) • Africa – women dying most from AIDS – 3:1 ratios • South Africa – Direct link of IPV with HIV+ status Dunkle, Jewkes et. al. The Lancet 363:1415-21 ’04 • Fonck, Kidula – Nairobi, Kenya – AIDS & Behavior ’05 • Maman et al – Tanzania – ‘02 • Women at risk – heterosexual married women with few or no behavioral risk factors • Husbands having sex with other women without wives’ knowledge &/or forcing sex (WHO ’05)

  12. HIV/DV Connections – Etiology (Maman et. al. ’99; Outwater & Campbell ’05; Tietleman et al in ‘08) • Immune system depression with stress – decrease time from HIV+ to full AIDS (<250 CD4 count) • Trauma increasing HIV transmission; anal sex • Increased STD’s & untreated STD’s (Letourneau ‘99; Coker et.al. ’00; King et. al. ’00) • Impossible to negotiate safe sex if a battering relationship • Women accused of infidelity if want to use safe sex • Males have other partners unknown to women (WHO multicountry study ’04) • Fear of being beaten for being tested; notifying partner of positive status; delay in treatment • Substance abuse

  13. MENTAL HEALTH EFFECTS - Golding ‘99 • Depression 10 - 43 pop; 32 - 70% clinical (9.3% non abused) • Suicidality 14 - 40% (4.9% non abused) • Post Traumatic Stress Disorder 2 - 12% pop; 31 - 84% clinical (weighted X prevalence 64% - 5% non abused) • Alcohol Abuse 4 - 16% pop; 23 - 44% clinical • Drug Abuse 5 - 16% pop; 23 - 44% clinical (2% non abused) • Eating Disorders - bulimia (McCauley et.al.1995)

  14. Bio-Psycho-Immunologic Response to Trauma IPV Depression Comorbid PTSD HPA axis  cortisol HPA axis cortisol Th1 shift Th2 shift Immune Suppression IgE/IgA Response Pro-Inflammatory

  15. Pro Inflammatory Response • Associations with chronic pain – Woods et al ’05 (fibromyalgia) • Other inflammatory conditions – asthma – chronic fatigue syndrome, urinary tract infections • Implications for BMI, obesity • Implicated with cardiovascular disease • ACE study

  16. Co-Morbidity of PTSD & Depression in Battered Women • Far more comorbidity in battered women than in rape victims or Vietnam Vets – in fact recent research suggests that only depression IF PTSD (Woods ’05) • Predictors: childhood victimization, – importance of child abuse on physical health – ACE • Importance of severity of physical abuse • Lifetime trauma response? • Issues of ongoing trauma

  17. Abuse During Pregnancy • 8-22% of pregnant women (vs. 7% pre-eclampsia or hypertension during pregnancy) • Most significant risk factor - abuse before pg. • Pregnancy - protective period or risk period (1st pregnancy - jealousy); usually neither • Ethnic group comparison - significantly lower in Hispanic couples (Mexican American) -14% vs. 16% in African American and Anglo (McFarlane & Parker ‘92)

  18. Prevalence of Abuse Around Time of Pregnancy (Saltzman et. al. ’03)

  19. Abuse During Pregnancy • Maternal health correlates: depression, substance abuse, low social support, spontaneous abortion, smoking, risk of homicide (Gielen ‘94; Campbell ‘92) • Perinatal mortality (death btw 28 weeks gestation to 28 days after delivery): 5 of 8 studies - (Coker ‘04; Janssen ‘03; Leung ‘01; Lipsky ‘04; Pikarinen ‘07; Taft ‘08; Yost ‘05) • Infant outcomes: LBW – meta analysis (Murphy et al ‘01) especially in MC women (Bullock & McFarlane ‘89) & through connections w/ smoking, low weight gain & substance abuse (Curry et al ‘99)

  20. Gaps in literature / Future Directions • More comprehensive measurement of IPV (e.g. overlapping types, frequency, duration, age at first experience; lifetime trauma) to establish dose-response. • Cohort studies to establish temporal sequence. • Mediators & moderators of effects of IPV on health. (resiliency and risk) • Need biologic markers to determine physiological mechanisms on how IPV adversely affects health. e.g. immune functions, neuroendocrine response and measures of vascular response. • Validate health outcomes with medical records or biologic testing when possible. • Replication of studies particularly for chronic disease

  21. Interventions in Health Care system • Mixed reviews on routine inquiry • Sufficient prevalence and health consequences • Sufficient evidence of acceptance by women (e.g. Gielen, Campbell et al ’06; ‘00) • Sufficient evidence of methods of inquiry – questions & strategy & system (e.g Trautman et al ‘07; Campbell ‘92; Rabin et al AJPV ‘09) • But insufficient evidence of intervention efficacy – 2 trials completed & to be reported on ‘09 • Two trials in home visitation settings underway • More intervention development & trials needed – other settings - e.g. substance abuse Tx

  22. Challenges remain • IOM committees - reports ’98; ’02 – workshop ‘09 – global • recommendations for funding for research; centers on family violence; training for researchers – few recommendations followed through • Sporadic NIH RFA’s – CDC funding continuous but new calls yearly - insufficient for full clinical trials, sustained programs of research

More Related